|
|
 |
|
Viewing report
|
|
|
|
Sun Pharmaceuticals Generics Company Intelligence Report
Espicom Business Intelligence Ltd, Jan 2011, Pages: 24
India-based Sun Pharmaceutical Industries was established in 1983, initially selling psychiatry-related products in West Bengal and Bihar. Sun has grown to be an international company with 17 manufacturing locations and a presence in 30 countries.
Group companies include the US-based Caraco Pharmaceutical Laboratories, in which Sun holds a majority stake. Caraco had sales of over US$337 million in 2008/09, but has faced regulatory issues in 2009 which has led to products being seized by the FDA.
Sun has a strong presence in cardiology, diabetes and neurology.
Sun reported annual sales in FY2008/09 worth Rs42,723 million (US$932.2 million), with total revenues worth Rs44,808.1 million (US$977.7 million). This was an increase over the prior year of 27% and 28%, respectively. Profit after tax reached Rs18,177.3 million (US$396.6 million), up by 22% over the prior year.
Since the middle of 2007, Sun has been in a battle to acquire the Israel-based Taro Pharmaceutical Industries. The effort has become increasingly bitter, and has been heard in Israel's Supreme Court. Sun finally won control of Taro in September 2010.
Executive Summary
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into the company, covering the structure of the business, the most recent quarterly and annual financial results, information on the company's active product lines and ANDA approvals, along with a review of major developments, such as M&A activity, strategic alliances, and litigation.
Customers who bought this item also bought
Sun Pharmaceutical Industries Limited - Product Pipeline Review - H2 2011
Sun Pharmaceutical Industries Limited - Product Pipeline Review - Q4 2010
Sun Pharmaceutical Industries Limited - Product Pipeline Review - Q4 2010
Sun Pharmaceutical Industries Limited - Product Pipeline Review - Q2 2011
Aurobindo Generics Company Intelligence Report
Taro Pharmaceuticals Industries Ltd - Strategy, SWOT and Corporate Finance Report
Wockhardt Generics Company Intelligence Report
Cipla Generics Company Intelligence Report
Dr Reddy's Laboratories Generics Company Intelligence Report
Taro Pharmaceutical US Inc.
|
|
|
|
